Neurology - STAT

In the Lab By Theresa Gaffney

Studying brain organoids with a Neanderthal gene, scientists unlock clues to modern human evolution

Health Tech By Mario Aguilar

Apple Watch can help track Parkinson’s disease symptoms, research shows

Biotech By Adam Feuerstein and Damian Garde

FDA delays approval decision for Biogen’s Alzheimer’s treatment

Health By Theresa Gaffney

Scientists create a thermostat for blood pressure to help patients with spinal cord injuries

In the Lab By Kate Sheridan

New research underscores the link between multiple sclerosis and the gut microbiome

Health By Priyanka Runwal

New screening technique turns up genes tied to microcephaly, scientists say, and could be used for other developmental disorders

Health By Andrew Joseph

Her father developed dementia. She made a documentary — a surreal, hilarious one — about the end of his life

In the Lab By Meghana Keshavan

Experimental drug for ALS, dreamed up in a dorm room, offers patients glimmer of hope

Health By Natalya Ortolano

‘We do belong here’: The scientist behind #BlackInNeuro hopes to transform a Twitter movement into a lasting community

Pharmalot By Ed Silverman

Pharmalittle: FDA approves another Duchenne muscular dystrophy drug; European orphan drug incentives questioned

Biotech By Kate Sheridan

4 questions for neurology startups as venture investors pour millions into the field

In the Lab By Natalya Ortolano

A preliminary new method could restore the brain cells Parkinson’s disease patients lost

Pharmalot By Ed Silverman

Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs

Biotech By Elizabeth Cooney

Startup Spotlight: Aiming to speed precision cancer therapies to children

The Readout LOUD By Damian Garde and Rebecca Robbins

Listen: Covid-19 in the White House, an audacious approach to Parkinson’s, and the public health lessons from porn

Health By Sharon Begley

Ethics questions swirl around historic Parkinson’s experiment

In the Lab By Elizabeth Cooney

A ‘sniff test’ signals consciousness after a brain injury, study shows

Biotech By Kate Sheridan

Two companies bet on ‘chemogenetics’ to sidestep challenges with neurological drug development

First Opinion By Meredith O'Brien

A chronic illness conundrum: Should I tell my employer about my MS?

First Opinion By Keita Mori

The U.S. needs a nationwide registry for traumatic brain injury

In the Lab By Sharon Begley

They have ‘Alzheimer’s brains’ but no symptoms. A new wave of drug developers wants to know why

Pharmalot By Ed Silverman

ICER, the controversial cost-effectiveness watchdog, reverses course on two migraine drugs

Pharmalot By Ed Silverman

Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence

First Opinion By Donna Jackson Nakazawa

Microglia: a new target in the brain for depression, Alzheimer’s, and more?

Biotech By Matthew Herper

Most Read

Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder

The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades

Trump wasn’t always so linguistically challenged. What could explain the change?

When even soft noises feel like a knife to the eardrums

When Covid-19 hits the brain, it can cause strokes, psychosis and a dementia-like syndrome, new survey shows

Muhammad Ali and Parkinson’s disease: Was boxing to blame?

Giving blood thinners to severely ill Covid-19 patients is gaining ground

A secret experiment revealed: In a medical first, doctors treat Parkinson’s with a novel brain cell transplant

All Coverage

Studying brain organoids with a Neanderthal gene, scientists unlock clues to modern human evolution

Apple Watch can help track Parkinson’s disease symptoms, research shows

FDA delays approval decision for Biogen’s Alzheimer’s treatment

Scientists create a thermostat for blood pressure to help patients with spinal cord injuries

New research underscores the link between multiple sclerosis and the gut microbiome

New screening technique turns up genes tied to microcephaly, scientists say, and could be used for other developmental disorders

Her father developed dementia. She made a documentary — a surreal, hilarious one — about the end of his life

Experimental drug for ALS, dreamed up in a dorm room, offers patients glimmer of hope

‘We do belong here’: The scientist behind #BlackInNeuro hopes to transform a Twitter movement into a lasting community

Pharmalittle: FDA approves another Duchenne muscular dystrophy drug; European orphan drug incentives questioned

4 questions for neurology startups as venture investors pour millions into the field

A preliminary new method could restore the brain cells Parkinson’s disease patients lost

Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs

Startup Spotlight: Aiming to speed precision cancer therapies to children

Listen: Covid-19 in the White House, an audacious approach to Parkinson’s, and the public health lessons from porn

Ethics questions swirl around historic Parkinson’s experiment

A ‘sniff test’ signals consciousness after a brain injury, study shows

Two companies bet on ‘chemogenetics’ to sidestep challenges with neurological drug development

A chronic illness conundrum: Should I tell my employer about my MS?

The U.S. needs a nationwide registry for traumatic brain injury

They have ‘Alzheimer’s brains’ but no symptoms. A new wave of drug developers wants to know why

ICER, the controversial cost-effectiveness watchdog, reverses course on two migraine drugs

Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence

Microglia: a new target in the brain for depression, Alzheimer’s, and more?

A venture firm warms to funding neuroscience